{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:34:11Z","timestamp":1780054451581,"version":"3.54.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T00:00:00Z","timestamp":1393804800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090348","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T21:52:23Z","timestamp":1393883543000},"page":"e90348","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Systematic Review and Meta-Analysis of L1-VLP-Based Human Papillomavirus Vaccine Efficacy against Anogenital Pre-Cancer in Women with Evidence of Prior HPV Exposure"],"prefix":"10.1371","volume":"9","author":[{"given":"Ada","family":"Miltz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huw","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shahmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Copas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","article-title":"Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials","volume":"369","author":"IISG FUTURE","year":"2007","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"M Schiffman","year":"2007","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"K53","DOI":"10.1016\/j.vaccine.2008.06.002","article-title":"An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results","volume":"26","author":"JT Schiller","year":"2008","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.vaccine.2006.04.068","article-title":"Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18","volume":"24","author":"LL Villa","year":"2006","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1016\/j.vaccine.2007.03.049","article-title":"Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6\/11\/16\/18 L1 virus-like particle (VLP) vaccine","volume":"25","author":"SE Olsson","year":"2007","journal-title":"Vaccine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/597309","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16\u201326 years","volume":"199","author":"CM Wheeler","year":"2009","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/11205060-000000000-00000","article-title":"Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil(R)) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women","volume":"25","author":"PL McCormack","year":"2011","journal-title":"BioDrugs"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/aje\/kwg171","article-title":"Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study","volume":"158","author":"M Molano","year":"2003","journal-title":"Am J Epidemiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ijc.10825","article-title":"Prevalence of human papillomavirus infection in women in Busan, South Korea","volume":"103","author":"HR Shin","year":"2003","journal-title":"Int J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1016\/j.vaccine.2012.04.006","article-title":"Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation","volume":"30","author":"R Howell-Jones","year":"2012","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Olsson SE (2006) Post-infection prophylaxis of a quadrivalent HPV (types 6,11,16,18) L1 VLP vaccine: a combined analysis [abstract]. European Research Organization on Genital Infection and Neoplasia (EUROGIN): 6th International Multidisciplinary Congress. Paris.","DOI":"10.1016\/j.ejogrb.2006.06.025"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"IISG FUTURE","year":"2007","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"A Hildesheim","year":"2007","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4161\/hv.5.10.9515","article-title":"Evaluation of quadrivalent HPV 6\/11\/16\/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection","volume":"5","author":"SE Olsson","year":"2009","journal-title":"Hum Vaccin"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/bjc.2011.185","article-title":"End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age","volume":"105","author":"X Castellsague","year":"2011","journal-title":"Br J Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ijc.26362","article-title":"HPV PATRICIA Study Group. Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15\u201325 years with and without serological evidence of previous exposure to HPV-16\/18","volume":"131","author":"A Szarewski","year":"2011","journal-title":"Int J Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2013.04.050","article-title":"Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)","volume":"130","author":"WD Kang","year":"2013","journal-title":"Gynecol Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1136\/bmj.e1401","article-title":"Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data","volume":"344","author":"EA Joura","year":"2012","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"M Lehtinen","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","article-title":"Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials","volume":"369","author":"EA Joura","year":"2007","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"LL Villa","year":"2005","journal-title":"Lancet Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000192397.41191.fb","article-title":"Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial","volume":"107","author":"C Mao","year":"2006","journal-title":"Obstet Gynecol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"SM Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"MRE McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref26","unstructured":"Harbord RM, Harris RJ, Sterne JAC (2009) Updated tests for small-study effects in meta-analysis. In: Sterne JAC, editor.Meta-analysis in stata: an updated collection from the stata journal.Texas: Stata Press. pp. 138\u2013150."},{"key":"ref27","unstructured":"Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, <etal>et al<\/etal>.. (2009) Metan: fixed- and random-effects meta-analysis. In: Sterne JAC, editor.Meta-analysis in stata: an updated collection from the stata journal.Texas: Stata Press. pp. 29\u201354."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"RM Harbord","year":"2006","journal-title":"Stat Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"b2981","DOI":"10.1136\/bmj.b2981","article-title":"Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications","volume":"339","author":"SG Moreno","year":"2009","journal-title":"BMJ"},{"key":"ref30","unstructured":"Higgins JPT, Green S (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration."},{"key":"ref31","unstructured":"StataCorp (2009) STATA statistical software. 11 ed. Texas."},{"key":"ref32","unstructured":"PRISMA (2009) PRISMA Checklist [online]."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"J Paavonen","year":"2007","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4161\/hv.5.10.9518","article-title":"Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18\u201345 years","volume":"5","author":"MH Einstein","year":"2009","journal-title":"Hum Vaccin"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24\u201345 years: a randomised, double-blind trial","volume":"373","author":"N Munoz","year":"2009","journal-title":"Lancet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-11-13","article-title":"Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review &amp; meta-analysis","volume":"11","author":"B Lu","year":"2011","journal-title":"BMC Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"J Paavonen","year":"2009","journal-title":"Lancet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T03:36:12Z","timestamp":1565235372000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090348"}},"subtitle":[],"editor":[{"given":"Michael","family":"Scheurer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,3]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090348","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,3]]}}}